National Cancer Institute - Hormone Therapy - Breast Cancer

National Cancer Institute is running a clinical trial to use hormone therapy with or without Everolimus to treat breast cancer.

Trial Name:  Hormone Therapy with or without Everolimus in Treating Patients with Breast Cancer

Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1286 locations

Everolimus, trade name Afinitor®, is a drug for treating advanced breast cancer when other drugs failing to work, and some other types of cancers.

Hormone Therapy is to use female hormones estrogen and progesterone to treat symptoms and diseases.

Please find details on www.cancer.org.

 

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.